Academic literature on the topic '342.56 (043.2)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '342.56 (043.2).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "342.56 (043.2)"

1

Bowmaker, Graham A., Jack M. Harrowfield, Peter C. Junk, Brian W. Skelton, and Allan H. White. "Syntheses, Structures and Vibrational Spectra of Some Dimethyl Sulfoxide Solvates of Bismuth(III) Bromide and Iodide." Australian Journal of Chemistry 51, no. 4 (1998): 285. http://dx.doi.org/10.1071/c97035.

Full text
Abstract:
Room-temperature single-crystal X-ray studies are recorded for some dimethyl sulfoxide (dmso) solvates of bismuth(III) bromide and iodide. Colourless BiBr3.3dmso is triclinic, P-1, a 8·467(4), b 9·109(4), c 13·901(4) Å, α 76·34(4), β 76·95(4), γ 64·56(4)°, Z = 2; conventional R on |F| was 0·050 for No 2306 independent ‘observed’ (I > 3σ(I)) reflections. The complex is mononuclear with a quasi-octahedral fac-bismuth environment, [(dmso-O)3BiBr3], isomorphous with the previously determined chloride. Orange BiI3-2dmso is triclinic, P-1, a 12·558(2), b 8·962(2), c 8·342(1) Å, α 61·85(1), β 78·2
APA, Harvard, Vancouver, ISO, and other styles
2

Fontaine, C., M. Huizing, A. Dewaele, et al. "Overnight fasting serum cholesterol, HDL, LDL and triglycerides levels and bone mineral density (BMD) values during adjuvant letrozole in daily practice." Journal of Clinical Oncology 25, no. 18_suppl (2007): 11040. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.11040.

Full text
Abstract:
11040 Background: Background: Randomized clinical trials (RCT’s) have demonstrated a superiority of adjuvant aromatase inhibitors (AI’s) over tamoxifen (TAM) in disease free survival and overall survival, immediately postoperatively, in cross-over or extended setting in hormone receptor positive BC. In these studies AI’s were associated with increased bone demineralization and a rise in non- fasting serum cholesterol. Patients and methods: The tolerance for adjuvant letrozole was reviewed in 185 postmenopausal women with hormone receptor-positive early BC including fasting cholesterol levels a
APA, Harvard, Vancouver, ISO, and other styles
3

Fedyanin, Mikhail, Alexey Tryakin, Alla Sergeevna Lisyanskaya, et al. "Results of a completed first-in-human phase Ib dose-escalation study of oral CBL0137 in patients with advanced solid tumors." Journal of Clinical Oncology 38, no. 15_suppl (2020): 3607. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.3607.

Full text
Abstract:
3607 Background: Curaxin CBL0137 is a novel compound with broad anticancer activity in animal models. The drug is a non-genotoxic DNA intercalator that interferes with histone/DNA binding causing decondensation of chromatin in tumor cells, functional inactivation of histone chaperone FACT, activation of p53 and IFN responses, and inhibition of pro-cancer transcriptional factors, MYC, NF-kB, HSF1, and HIF1a. Methods: The study enrolled adults with advanced chemorefractory solid tumors, ECOG PS ≤2, and adequate organ function. The primary objective was to find the maximum tolerated dose (MTD) an
APA, Harvard, Vancouver, ISO, and other styles
4

Herrero-Morant, A., J. Loricera, I. Ferraz-Amaro, et al. "AB0707 PREDICTIVE FACTORS OF RELAPSE IN GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 1557.2–1558. http://dx.doi.org/10.1136/annrheumdis-2023-eular.4399.

Full text
Abstract:
BackgroundTocilizumab (TCZ) is the only biologic therapy approved for giant cell arteritis (GCA). Clinical trials with TCZ in GCA was performed with intravenous (iv) TCZ in a phase 2 trial[1], and with subcutaneous (sc) TCZ in the phase 3 GiACTA[2].There is general agreement on the initial/maintenance dose, but duration of TCZ therapy is not well established. In GiACTA trial, after one year on TCZ, most patients had GCA relapse after withdrawal.ObjectivesTo assess the predictive factors of relapse in GCA in a clinical practice scenario.MethodsMulticentre observational study of 471 patients wit
APA, Harvard, Vancouver, ISO, and other styles
5

Szabó, A., J. Nagy, J. Bokor, et al. "Clinical chemistry of farmed red deer (<i>Cervus elaphus</i>) yearling hinds reared on grass or <i>papillonaceous</i> pasture paddocks in Hungary." Archives Animal Breeding 56, no. 1 (2013): 443–54. http://dx.doi.org/10.7482/0003-9438-56-043.

Full text
Abstract:
Abstract. Yearling red deer (Cervus elaphus) hinds of identical initial body weight were reared on a monocotyledonous grass (group 1) or on a papillonaceous plant pasture (group 2) for 212 days. At the end of the experiment (when deer were shot) blood was taken from ten animals of each group for serum biochemical analysis. Hinds of group 2 provided higher final body weight (90±3.5 vs. 101±6.6 kg) and higher daily body weight gain (105.7±10.7 vs. 153.8±26.8 g/day). Within serum nitrogenous compounds group 2 provided higher total protein concentrations, while from the lipids only serum triglycer
APA, Harvard, Vancouver, ISO, and other styles
6

Yoneyama, Takahiro, Yuki Tobisawa, Tohru Yoneyama, et al. "Carboplatin-based sequential chemotherapy for aged patients with advanced bladder cancer." Journal of Clinical Oncology 33, no. 7_suppl (2015): 342. http://dx.doi.org/10.1200/jco.2015.33.7_suppl.342.

Full text
Abstract:
342 Background: We retrospectively evaluated the feasibility and effectiveness of carboplatin based chemotherapy for the patients 65 years or older with advanced bladder cancer. Methods: We treated 86 patients with advanced bladder cancer at our clinic between August 2004 and June 2014. 56 patients (40 men and 16 women) with the age of 65 years or older were enrolled. Their average age was 75.8 years old (65–86), average Ccr was 54.4 ml/min (14.5–113.0), and an average follow-up period was 21.7 months (2–81). There were 18 recurrent cases after radical surgery and 38 inoperable cases. The ther
APA, Harvard, Vancouver, ISO, and other styles
7

Sharma, Sumeet. "Knowledge and attitude towards orthodontic treatment among adolescent patients visiting a private dental clinic in Udaipur City, Rajasthan: a cross-sectional descriptive study." Journal of Research in Dentistry 5, no. 3 (2018): 51. http://dx.doi.org/10.19177/jrd.v5e3201751-56.

Full text
Abstract:
Aim: Present study is conducted to put some light on the knowledge and attitude of adolescents coming to private dental clinicMaterial and Methods: The present study was conducted on adolescent subjects visiting a private dental clinic for various reasons. The study was conducted in May- June 2017. In these 2 months out of total patients a total of 342 adolescents had visited to the clinic. Out of which 293 adolescents had given there informed consent were included in the study. A structured close ended questionnaire was prepared to check the Knowledge and attitude of the study participants.Re
APA, Harvard, Vancouver, ISO, and other styles
8

Chang, Yifan, Yue Xuan, Ruinan Zhang та ін. "Effects of Dietary Schizochytrium Algae as ω-3 PUFA Source on the Egg-Laying Quail Performance, Serum Indexes, and Egg Yolk Fatty Acids Contents". Animals 15, № 1 (2024): 21. https://doi.org/10.3390/ani15010021.

Full text
Abstract:
The objective of this experiment is to investigate the effects of SAP or SAO as ω-3 PUFA raw materials on production performance, egg quality, serum immunity, serum lipids, and fatty acid deposition patterns in the eggs of laying quails. Chinese yellow-feathered quails served as the experimental subjects. A single-factor design was employed to randomly assign 1288 quails into four treatment groups, with seven replicates per treatment and 46 birds in each replicate. The groups included a control group (basal diet with no SAP), 1.6% SAP, 3.2% SAP, and 0.8% SAP + 0.3% SAO. The results indicate th
APA, Harvard, Vancouver, ISO, and other styles
9

Zammit, Gary, David Mayleben, Ingo Fietze, et al. "344 Daridorexant Improves Total Sleep Time (TST) in Insomnia Patients Without Altering the Proportion of Sleep Stages." Sleep 44, Supplement_2 (2021): A137—A138. http://dx.doi.org/10.1093/sleep/zsab072.343.

Full text
Abstract:
Abstract Introduction Daridorexant, a new dual orexin receptor antagonist, improved sleep parameters and daytime functioning in two pivotal Phase 3 trials in patients with insomnia (Trial-1, NCT03545191; Trial-2, NCT03575104); polysomnography data were collected at multiple timepoints from &amp;gt;1,800 patients. We report the effects of daridorexant on TST and sleep stages from both trials. Methods Eligible patients with insomnia (according to DSM-5) were randomized (1:1:1) in Trial-1 (N=930) to daridorexant 25mg, 50mg, or placebo and in Trial-2 (N=924) to daridorexant 10mg, 25mg, or placebo.
APA, Harvard, Vancouver, ISO, and other styles
10

Mazari, Muhammad Ejaz, Fazal ur Rehman, and Muhammad Ashfaq Zafar. "Hypoglycemia in Newborns with risk factors of hypoglycemia." Professional Medical Journal 27, no. 01 (2020): 84–88. http://dx.doi.org/10.29309/tpmj/2019.27.01.3333.

Full text
Abstract:
Objectives: Hypoglycemia is a matter of great concern especially in newborns. Its prevalence varies globally as different protocols and feeding policies exist. We aimed this study to find out the incidence of hypoglycemia in newborns with risk factors of hypoglycemia. Study Design: Observational study Setting: Pediatric Medicine Unit-2, Mayo Hospital, Lahore. Period: From 1st January 2018 to 31st December 2018. Material &amp; Methods: A total of 342 babies born with risk factors for hypoglycemia fulfilling the inclusion and exclusion criteria were considered for this study. Screening for hypog
APA, Harvard, Vancouver, ISO, and other styles
More sources
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!